Medical Manager

AARATI RAI, Ph.D. M.B.A (Candidate)

**** *** *** **.

Arlington Heights, IL 60004

Phone: 1-847-***-****

Email: ******.***@*****.***

OBJECTIVE

Clinical subject matter expert with 7 years of immunology experience in

autoimmune diseases and success integrating global teams, developing key

opinion leaders (KOLs), supporting clinical trial programs and implementing

global knowledge management solutions, seeking exposure in marketing and medical billing.

Medical Affairs, Medical Advisor, Clinical, Strategic Marketing, Compliance-

Regulatory, Mechanism of Action, Biologic Therapeutics, Therapeutic

Antibodies, Autoimmune Diseases, Immunology, Rheumatology,

Gastroenterology, Dermatology, Ophthalmology, Oncology, KOL Development,

Functional management of medical liaison team, Investigator-Initiated

Studies, Phase IIIb/IV Trials, Internal Training, Advisory Boards, Product

and Technology Analysis, Publications, Presentations

SUMMARY

I provide input on specialized medical/scientific strategic and operational

input into core medical affairs activities such as: health-care

professional/provider interactions; generation of clinical and scientific

data (enhancing therapeutic benefit and value); educational initiatives

(medical education, data, guidelines and value proposition); safeguarding

patient safety (risk minimization activities / safety surveillance

activities). I work closely with sales, marketing and commercial teams to

provide strategic medical input into core brand strategies, and to support

medical/marketing activities (promotional material generation/product

launches) and market access. I provide scientific and technical support for

assigned products; deliver scientific presentations; identify national and

regional KOL network and develop relationships with KOLs; and develop

innovative research concepts for clinical data generation.

ACHIEVEMENTS

. Developed national strategies for field-based personnel in alignment

with brand goals. Successful translation into regional HCP outreach

and education plans resulted in our team being viewed as most

favorable and unbiased by HCPs in a national independent survey,

ultimately earning the company more credibility with physicians.

. Managed multi-national strategic projects that involved facilitation

of affiliate congress activities worldwide. Recognized for reducing

redundancies, addressing local affiliate needs, and creating impactful

resources, requested by all worldwide affiliates.

. Established a national KOL network for a first-in-class rare disease

indication. Identifying this list of KOLs enabled the company to move

forward with the clinical program. This network is now the source for

all clinical trial sites in this indication. Recognized for problem

solving in building relationships with top KOLs.

PROFESSIONAL EXPERIENCE

Clinical Integration Manager (Sr. Medical Advisor), Abbvie (formerly

Abbott) 2007-2013

Knowledge and Liaison Management

. Identified national KOL network for new first-in-class indication for

advisory boards, speaker programs, and publications

. Subject matter expert in oncology and autoimmune diseases: Psoriasis,

Rheumatoid Arthritis, Crohn's Disease, Spondyloarthropathies, and

Hidradenitis Suppurativa

. Primary clinical liaison for field-based support of KOLs and

resolution of scientific issues

. Manage 20 medical liaison's function and support their territory

management and KOL support

. Build Key Performance Indicators (KPI) and ensure measurable success

through quantitative impact to the organization

. Communication hub between field-based medical liaison team and

internal stakeholders

. Provided clinical and scientific direction for global brand planning

. Developed high quality scientific educational resources

. Developed state-of-the-art clinical and professional skills training

program

. Provided direction on development of global publication strategy

. Aligned organization initiatives with FDA/Legal-Regulatory compliance

guidelines

. Implemented Corporate Integrity Agreement compliance action plan

. Developed knowledge management plans and strategies to prepare for US

biosimilar launches

Clinical Trial Program Support

. Core clinical team supporting Phase III global clinical trial

coordination

. Primary clinical liaison for field-based support of clinical trials

and registries through trial site identification, patient enrollment

and triaging site investigator issues

. Evaluated investigator-initiated study proposals for clinical support

. Educated speakers on promotional speaker programs

Strategic Planning

. Provided leadership and strategic clinical direction across a matrix

team

. Build relationship with national medical organizations, patient

foundations and advocacy groups

. Integrated internal departments to ensure smooth product launches by

building marketplace, managing KOL interest, feedback, and education

. Translated global strategy to regional action plans

Clinical Science Manager (Medical Science Liaison), Abbott

2010

. Created awareness of new clinical program by establishing

relationships and developing KOLs in the medical community

. Provided key peer-to-peer scientific exchange

. Educated top dermatology KOLs in US pacific northwest region on

current product, disease state, and regulations information

. Performed speaker training for promotional speaker programs

. Scientific resource for medical congresses competitive intelligence,

advisory boards, and adverse event reporting

Senior Medical Writer, Abbott Laboratories, Abbott Park, IL

2005-2007

. Collaborated with KOLs on 43 Clinical and Health Economics and

Outcomes Research abstracts and posters and co-authored manuscript

. Applied industry policies and best practices in global publications

. Collaborated across a matrix team to support development of clinical

publication strategy

Research Assistant, Department of Biopharmaceutical Sciences, UIC, Chicago

1999-2005

. Researched, wrote, and edited scientific manuscripts for publication

in peer-reviewed journals

. Led research projects in oncology and cardiovascular therapeutic areas

. Prepared research proposals and grant budgets for government funding

EDUCATION

. Loyola University - Ongoing

Executive M.B.A - Healthcare Management

. University of Illinois at Chicago (UIC) - 2005

Ph.D., in Pharmacodynamics and Pharmacokinetics

. Ohio State University - 1997

Bachelor of Science, Biology

SELECTED PUBLICATIONS

. Young MS, Furfaro N, and Rai A. 2009. Diagnosis and Management of

Psoriatic Arthritis: A Practical Review. J Derm Nurses Assoc. 1(5):283-

293.

. Rai, A, NV Rajeshkumar, Shord S, and Gulati A. 2005. ETB receptor

agonist, IRL 1620, does not affect paclitaxel plasma pharmacokinetics

in breast tumor bearing rats; J Pharmacy Pharmacol. 57(7): 869-76.

. NV Rajeshkumar, Rai, A, and Gulati A. 2005. Endothelin B receptor

agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in

breast tumor rats. Breast Cancer Res Treat. 94(3): 237-47.

. Rai, A, Bhalla S, Rebello S, Kastrissios H, and Gulati A. 2005.

Disposition of morphine in plasma and cerebrospinal fluid varies

during neonatal development in pigs; J Pharmacy Pharmacol. 57(8): 981-

6.

. Rai, A, Bhalla S, and Gulati A. 2004. Endothelin ETA receptor

antagonist did not affect development of tolerance to glyceryl-

trinitrate in rat; J Pharmacy Pharmacol. 56(2): 271-5.

. Gulati, A and Rai, A. 2004. Endothelin-1 induced vasodilatation in rat

breast tumor is mediated through ETB receptors. J Cardiovasc

Pharmacol. 44: S483-6.

. Rai, A, and Gulati, A. 2003. Evidence for the involvement of ETB

receptors in ET-1-induced changes in blood flow to the rat breast

tumor. Cancer Chemother Pharmacol. 51(1): 21-8.

REFERENCES

Available upon request.

Contact this candidate